Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01783262
Other study ID # Interventional Study Design
Secondary ID
Status Completed
Phase N/A
First received January 29, 2013
Last updated January 31, 2013
Start date December 2009

Study information

Verified date January 2013
Source University of Roma La Sapienza
Contact n/a
Is FDA regulated No
Health authority Italy: La Sapienza University
Study type Interventional

Clinical Trial Summary

Evaluate if extracorporeal shock wave therapy is more effective than sham treatment in patients with trapezial-metacarpal osteoarthritis in pain relief and functional improvement.


Recruitment information / eligibility

Status Completed
Enrollment 0
Est. completion date
Est. primary completion date June 2011
Accepts healthy volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- according to the Eaton et al. classification the inclusion criteria involved those patients with stage III, participants had to have a history 6 months of pain and they were 18 years of age or older. Exclusion criteria were also the presence of degenerative or non-degenerative neurologic conditions, in which pain perception is altered, a history of coagulopathy, cancer, cardiac pacemaker, calcaneal fracture, and pregnancy.

Exclusion Criteria:

- Exclusion criteria were also the presence of degenerative or non-degenerative neurologic conditions, in which pain perception is altered, a history of coagulopathy, cancer, cardiac pacemaker, calcaneal fracture, and pregnancy.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Extracorporeal shock wave therapy STORZ MEDICAL Modulith SLK
an energy level of 0.09 mJ/mm2, 2400 pulses once a week for 4 weeks.
Device: Sham extracorporeal shock wave therapy STORZ MEDICAL Modulith SLK


Locations

Country Name City State
Italy La Sapienza University Rome

Sponsors (1)

Lead Sponsor Collaborator
University of Roma La Sapienza

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale It is a horizontal line, 10 cm in length with 0 cm labeled "no pain" and 10 cm labeled "worst pain I have ever had". The patient marks on the line the point that they feel represents their perception of their current state The change in the mean Visual Analogic Scale scores from baseline to 3 and 6 months after the intervention No
Primary Duruöz Hand Index (DHI) is a self-report questionnaire which measures hand functional ability detecting how much difficulty the patient has performing eighteen daily tasks of living in reference to hand function. Each item is scored from 0 (performed without difficulty) to 5 (impossible to do). A total score is obtained by adding the scores of all questions (range 0-90). A higher score indicates greater disability. It was found that this scale is reliable and valid in patients with osteoarthritis The change in the mean of DHI at 3 and 6 months follow up No
Primary Disabilities of the Arm, Shoulder, and Hand questionnaire It is a 30-item scale that addresses dif?culty in performing various physical activities that require upper extremity function (physical function, 21 items); symptoms of pain, activity-related pain, tingling, weakness, and stiffness (pain symptoms, 5 items); or impact of disability and symptoms on social activities, work, sleep, and psychological well-being (emotional and social function, 4 items). The score ranges from 0 to 100, where 0 disability and 100 most severe disability. The changes in mean at 3 and 6 months follow up
Secondary grip and pinch tests The measure of strength by hand grip and pinch tests, for continuous variables that were measured in kilograms with a standard dynamometer The change in mean at 3 and 6 months follow up